A nationwide study in Denmark showed a higher than expected risk of cardiac events in patients with cancer receiving immune checkpoint inhibitors 10 Dec, 2020 | 08:49h | UTC The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study – European Heart Journal Commentary: Cancer patients receiving immunotherapy drugs have a higher risk of heart problems – European Society of Cardiology